Correction for the Influence of Cataract on Macular Pigment Measurement by Autofluorescence Technique Using Deep Learning.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
05 02 2021
Historique:
entrez: 18 5 2021
pubmed: 19 5 2021
medline: 29 6 2021
Statut: ppublish

Résumé

Measurements of macular pigment optical density (MPOD) by the autofluorescence technique yield underestimations of actual values in eyes with cataract. We applied deep learning (DL) to correct this error. MPOD was measured by SPECTRALIS (Heidelberg Engineering, Heidelberg, Germany) in 197 eyes before and after cataract surgery. The nominal MPOD values (= preoperative value) were corrected by three methods: the regression equation (RE) method, subjective classification (SC) method (described in our previous study), and DL method. The errors between the corrected and true values (= postoperative value) were calculated for local MPODs at 0.25°, 0.5°, 1°, and 2° eccentricities and macular pigment optical volume (MPOV) within 9° eccentricity. The mean error for MPODs at four eccentricities was 32% without any correction, 15% with correction by RE, 16% with correction by SC, and 14% with correction by DL. The mean error for MPOV was 21% without correction and 14%, 10%, and 10%, respectively, with correction by the same methods. The errors with any correction were significantly lower than those without correction (P < 0.001, linear mixed model with Tukey's test). The errors with DL correction were significantly lower than those with RE correction in MPOD at 1° eccentricity and MPOV (P < 0.001) and were equivalent to those with SC correction. The objective method using DL was useful to correct MPOD values measured in aged people. MPOD can be obtained with small errors in eyes with cataract using DL.

Identifiants

pubmed: 34003903
pii: 2772277
doi: 10.1167/tvst.10.2.18
pmc: PMC7884288
doi:

Substances chimiques

Macular Pigment 0
Zeaxanthins 0
Lutein X72A60C9MT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Références

Exp Eye Res. 2013 Nov;116:190-8
pubmed: 24007642
Ophthalmic Epidemiol. 2002 Apr;9(2):83-95
pubmed: 11821974
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3011-3019
pubmed: 30025122
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2552-63
pubmed: 27163768
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3429-39
pubmed: 27367585
Transl Vis Sci Technol. 2018 Jul 9;7(4):3
pubmed: 30002950
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):439-46
pubmed: 11157880
Annu Rev Nutr. 2003;23:171-201
pubmed: 12626691
Invest Ophthalmol Vis Sci. 2011 Sep 22;52(10):7406-15
pubmed: 21296819
Mol Aspects Med. 2005 Dec;26(6):459-516
pubmed: 16309738
Ophthalmology. 2008 Feb;115(2):334-41
pubmed: 17664009
Retina. 2016 Jul;36(7):1381-7
pubmed: 26655614
Invest Ophthalmol Vis Sci. 2014 Apr 15;55(4):2376-83
pubmed: 24627145
Optometry. 2004 Apr;75(4):216-30
pubmed: 15117055
Eur J Ophthalmol. 2012 Mar-Apr;22(2):216-25
pubmed: 22009916
Transl Vis Sci Technol. 2019 Dec 18;8(6):41
pubmed: 31867142
Invest Ophthalmol Vis Sci. 2012 Nov 29;53(12):7871-80
pubmed: 23132800
J Opt Soc Am A Opt Image Sci Vis. 2008 Apr;25(4):947-57
pubmed: 18382494
Ophthalmology. 2002 Oct;109(10):1780-7
pubmed: 12359594
Curr Opin Ophthalmol. 2010 May;21(3):184-9
pubmed: 20216418
J Opt Soc Am A Opt Image Sci Vis. 2001 Jun;18(6):1212-30
pubmed: 11393613
Invest Ophthalmol Vis Sci. 1993 May;34(6):2033-40
pubmed: 8491553
Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):383-8
pubmed: 24081317
J Opt Soc Am A Opt Image Sci Vis. 2002 Jun;19(6):1172-86
pubmed: 12049355
Invest Ophthalmol Vis Sci. 2013 Jun 10;54(6):4034-40
pubmed: 23652486
Graefes Arch Clin Exp Ophthalmol. 2011 Mar;249(3):315-47
pubmed: 21221629
Arch Biochem Biophys. 2001 Jan 1;385(1):28-40
pubmed: 11361022
FEBS Lett. 1997 Nov 24;418(1-2):91-7
pubmed: 9414102
Arch Biochem Biophys. 2004 Oct 15;430(2):156-62
pubmed: 15369813
J Biomed Opt. 2010 Nov-Dec;15(6):061714
pubmed: 21198162
Ophthalmology. 2012 Nov;119(11):2290-7
pubmed: 22858124
Exp Eye Res. 2018 Mar;168:100-106
pubmed: 29357284
J Biomed Opt. 2014 Sep;19(9):96010
pubmed: 25223707

Auteurs

Akira Obana (A)

Department of Ophthalmology, Seirei Hamamatsu General Hospital, Hamamatsu City, Shizuoka, Japan.
Department of Medical Spectroscopy, Institute for Medical Photonics Research, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Kibo Ote (K)

Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Shizuoka, Japan.

Fumio Hashimoto (F)

Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Shizuoka, Japan.

Ryo Asaoka (R)

Department of Ophthalmology, Seirei Hamamatsu General Hospital, Hamamatsu City, Shizuoka, Japan.

Yuko Gohto (Y)

Department of Ophthalmology, Seirei Hamamatsu General Hospital, Hamamatsu City, Shizuoka, Japan.

Shigetoshi Okazaki (S)

Department of Medical Spectroscopy, Institute for Medical Photonics Research, Preeminent Medical Photonics Education & Research Center, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Hidenao Yamada (H)

Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Shizuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH